| Literature DB >> 25006821 |
Gregory J Fox1, Dinh Ngoc Sy2, Nguyen Viet Nhung2, Bing Yu3, Magda K Ellis4, Nguyen Van Hung2, Nguyen Kim Cuong5, Luu Thi Lien6, Guy B Marks7, Bernadette M Saunders8, Warwick J Britton8.
Abstract
BACKGROUND: Tuberculosis (TB) is an infectious disease that remains a major cause of morbidity and mortality worldwide, yet the reasons why only 10% of people infected with Mycobacterium tuberculosis go on to develop clinical disease are poorly understood. Genetically determined variation in the host immune response is one factor influencing the response to M. tuberculosis. SP110 is an interferon-responsive nuclear body protein with critical roles in cell cycling, apoptosis and immunity to infection. However association studies of the gene with clinical TB in different populations have produced conflicting results.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25006821 PMCID: PMC4090157 DOI: 10.1371/journal.pone.0099496
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of TB patients and controls.
| Cases (TB Patients) | Controls | |
| Number | 663 | 566 |
| Mean age, years (SD) | 44.6 (17.3) | 30.4 (10.6) |
| Males (%) | 485 (73.2%) | 214 (37.8%) |
| Vietnamese born (%) | 100% | 100% |
| HIV negative (%) | 618/638 (97%) | |
| Pulmonary TB | 530 | |
| Extrapulmonary TB | ||
| All forms | 133 | - |
| Lymph node | 9 | - |
| Meningeal | 7 | - |
| Pleural | 105 | - |
| Abdominal | 10 | - |
| Other | 2 | - |
HIV serology results were not available for 25 TB patients included in the study. 19 of these stated they had no past history of HIV and had no features of HIV, and data was missing for one subject. SD: standard deviation.
Figure 1Human SP110 genomic structure showing the location of tested tag SNPs.
Allelic frequencies for all tuberculosis patients.
|
|
|
|
|
|
|
|
|
|
|
| |
|
| G | T | 125 | (11%) | 1007 | (89%) | 191 | (14.5%) | 1129 | (85.5%) | 0.013 |
|
| C | T | 165 | (14.6%) | 967 | (85.4%) | 247 | (18.7%) | 1071 | (81.3%) | 0.007 |
|
| C | T | 191 | (16.9%) | 941 | (83.1%) | 262 | (19.8%) | 1058 | (80.2%) | 0.06 |
|
| C | T | 165 | (14.6%) | 967 | (85.4%) | 237 | (18%) | 1081 | (82%) | 0.025 |
|
| A | G | 342 | (30.2%) | 790 | (69.8%) | 447 | (33.9%) | 871 | (66.1%) | 0.051 |
|
| T | C | 8 | (0.7%) | 1124 | (99.3%) | 1 | (0.1%) | 1317 | (99.9%) | 0.015 |
|
| A | G | 129 | (11.4%) | 1003 | (88.6%) | 115 | (8.7%) | 1203 | (91.3%) | 0.03 |
|
| C | T | 8 | (0.7%) | 1124 | (99.3%) | 2 | (0.2%) | 1316 | (99.8%) | 0.052 |
SNP: Single nucleotide polymorphism. Rs number = Reference Single Nucleotide Polymorphism number.
*Unadjusted P-value calculated using Fisher’s exact test. Results presented for SNPs included in adjusted analysis.
Association of SNPs with pulmonary TB and extra-pulmonary TB by allelic analysis, by adjusted multivariate analysis.
| SNP | Group | OR (95% CI) Dominant model# | p-value | OR (95% CI) Recessive model# | p-value |
| rs10208770 |
|
| |||
| PTB |
|
| 3.01 (0.84–10.76) | 0.090 | |
| EPTB | 1.49 (0.92–2.42) | 0.106 | 5.33 (1.41–20.14) | 0.014 | |
| Pleural TB | 1.36 (0.79–2.33) | 0.266 |
|
| |
| All TB |
|
| 4 (1.28–12.58) | 0.017 | |
| rs10498244 |
|
| |||
| PTB | 1.52 (1.11–2.09) | 0.010 | 2.44 (0.9–6.65) | 0.081 | |
| EPTB | 1.42 (0.91–2.21) | 0.122 |
|
| |
| Pleural TB | 1.44 (0.89–2.34) | 0.139 |
|
| |
| All TB |
|
| 2.96 (1.23–7.09) | 0.015 | |
| rs1135791 |
|
| |||
| PTB | 1.36 (1–1.85) | 0.053 | 1.32 (0.57–3.06) | 0.522 | |
| EPTB | 1.41 (0.91–2.17) | 0.122 | 2.33 (0.89–6.11) | 0.085 | |
| Pleural TB | 1.37 (0.85–2.2) | 0.199 | 2.57 (0.92–7.18) | 0.072 | |
| All TB | 1.4 (1.05–1.86) | 0.021 | 1.61 (0.76–3.37) | 0.211 | |
| rs11678451 |
|
| |||
| PTB | 1.4 (1.02–1.93) | 0.038 | 1.13 (0.45–2.81) | 0.796 | |
| EPTB | 1.72 (1.11–2.66) | 0.014 | 1.4 (0.41–4.82) | 0.594 | |
| Pleural TB | 1.81 (1.13–2.91) | 0.014 | 1.8 (0.52–6.26) | 0.354 | |
| All TB | 1.54 (1.15–2.06) |
| 1.16 (0.5–2.69) | 0.722 | |
| rs16826860 |
|
| |||
| PTB | 1.5 (1.12–2.02) |
| 2.13 (1.33–3.43) |
| |
| EPTB | 1.2 (0.8–1.8) | 0.373 | 0.79 (0.35–1.76) | 0.565 | |
| Pleural TB | 1.21 (0.77–1.89) | 0.401 | 0.74 (0.3–1.84) | 0.523 | |
| All TB | 1.47 (1.12–1.92) |
| 1.74 (1.12–2.7) | 0.014 | |
| rs3948464 |
|
| |||
| PTB | na | na | 6.17 (0.74–51.69) | 0.093 | |
| EPTB | na | na | na | na | |
| Pleural TB | na | na | na | na | |
| All TB | na | na | 8.22 (0.99–68.42) | 0.051 | |
| rs7601176 |
|
| |||
| PTB | 7.01 (1.09–45.04) | 0.040 | 1.56 (1.07–2.25) | 0.019 | |
| EPTB | 0.66 (0.15–2.93) | 0.581 | 1.65 (0.95–2.86) | 0.076 | |
| Pleural TB | 0.94 (0.17–5.29) | 0.940 | 1.67 (0.9–3.11) | 0.107 | |
| All TB | 2.21 (0.54–9.05) | 0.268 | 1.64 (1.17–2.31) |
| |
| rs1427294 |
|
| |||
| PTB | na | na | 3.24 (0.65–16.17) | 0.152 | |
| EPTB | na | na | na | na | |
| Pleural TB | na | na | na | na | |
| All TB | na | na | 4.32 (0.87–21.36) | 0.073 |
Adj = Adjusted for age & gender. na = Not calculated as zero count in at least one cell of the two by two table. EPTB = extrapulmonary TB, All TB = all forms of TB. Pleural TB is a sub-set of extrapulmonary TB.
*indicates SNPs for which the p-value was below the adjusted effective study-wide level of statistical significance (<0.00775), taking into account the number of effective tests [31].
Figure 2Linkage Disequilibrium Plot of SNPs of SP110 with associations with tuberculosis.
Pairwise D′ values are written as a percentage in each square. High D′ values are dark, low D′ values are light. SNPs associated with tuberculosis in multivariate analysis shown above the plot.
Summary of SNPs in adjusted analysis for all tuberculosis patients.
|
|
|
|
|
|
|
| Potential effect on protein | |
| rs10208770 | G | T | 11% | 89% | 14.5% | 85.5% | 0.013 | No effect |
| rs10498244 | C | T | 14.6% | 85.4% | 18.7% | 81.3% | 0.007 | No effect |
| rs1135791 | C | T | 16.9% | 83.1% | 19.8% | 80.2% | 0.06 | Amino acid change M>T. Splice site changes. Possible downstream effect on bromo domain, Zn finger, SAND domain and nuclear localisation signal. |
| rs11678451 | C | T | 14.6% | 85.4% | 18% | 82% | 0.025 | No effect |
| rs16826860 | A | G | 30.2% | 69.8% | 33.9% | 66.1% | 0.051 | No effect |
| rs3948464 | T | C | 0.7% | 99.3% | 0.1% | 99.9% | 0.015 | L>S. Splice site changes. |
| rs7601176 | A | G | 11.4% | 88.6% | 8.7% | 91.3% | 0.03 | No effect |
| rs1427294 | C | T | 0.7% | 99.3% | 0.2% | 99.8% | 0.052 | No effect. |
SNP: Single nucleotide polymorphism. Rs number = Reference Single Nucleotide Polymorphism number.
Predicted functional effect on protein synthesis.
*P-value for unadjusted allelic association between all TB patients and control subjects calculated using Fisher’s exact test. M = Methionine, T = Threonine, S = serine, L = leucine.